SNTI (Senti Biosciences Holdings) 5-Year EBITDA Growth Rate: 7.40% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SNTI Senti Biosciences Holdings Inc SNTI
13 GF Score
Price $0.32
! 6 Warning Signs
View Full Analysis

What is Senti Biosciences Holdings 5-Year EBITDA Growth Rate?

Senti Biosciences Holdings SNTI +2.11% 13 5-Year EBITDA Growth Rate is 7.40% as of Jun. 2026. GuruFocus rates SNTI with a GF Score™ of 13/100. The stock has 6 warning signs investors should review.

Senti Biosciences Holdings's EBITDA per Share for the three months ended in Jun. 2026 was $-0.39.

During the past 3 years, the average EBITDA Per Share Growth Rate was 50.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Senti Biosciences Holdings was 50.70% per year. The lowest was -38.50% per year. And the median was -13.00% per year.

Senti Biosciences Holdings  (NAS:SNTI) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Senti Biosciences Holdings 5-Year EBITDA Growth Rate Related Terms

SNTI vs KPRX, PDSB, TOVX: 5-Year EBITDA Growth Rate Comparison

For the Biotechnology subindustry, Senti Biosciences Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senti Biosciences Holdings 5-Year EBITDA Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Senti Biosciences Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Senti Biosciences Holdings's 5-Year EBITDA Growth Rate falls into.


SNTI
13GF Score
Senti Biosciences Holdings Inc SNTI
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senti Biosciences Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 7.40% mean?
Senti Biosciences Holdings (SNTI) has a 5-Year EBITDA Growth Rate of 7.40% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Senti Biosciences Holdings and its competitors.
Is Senti Biosciences Holdings' 5-Year EBITDA Growth Rate too high?
Senti Biosciences Holdings' current 5-Year EBITDA Growth Rate is 7.40%. Overall, Senti Biosciences Holdings has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Senti Biosciences Holdings' 5-Year EBITDA Growth Rate compare to KPRX and PDSB?
Senti Biosciences Holdings' 5-Year EBITDA Growth Rate of 7.40% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Biotechnology company?
A good 5-Year EBITDA Growth Rate depends on the Biotechnology industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Senti Biosciences Holdings and its competitors. Senti Biosciences Holdings's current 5-Year EBITDA Growth Rate is 7.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senti Biosciences Holdings stock overvalued right now?
Senti Biosciences Holdings (SNTI) has a current 5-Year EBITDA Growth Rate of 7.40%. The current 5-Year EBITDA Growth Rate is 7.40%. Senti Biosciences Holdings' overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Senti Biosciences Holdings (SNTI), the current 5-Year EBITDA Growth Rate is 7.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Senti Biosciences Holdings Business Description

Address 2 Corporate Drive, First Floor, South San Francisco, CA, USA, 94080
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
13GF Score

Get the complete analysis for SNTI

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price